催眠增强抑郁症治疗中的行为激活
Barbara S McCann1, Arin Collin1
1University of Washington, Seattle, WA, USA.
The American journal of clinical hypnosis
|November 16, 2023
概括
行为激活是认知行为疗法 (CBT) 的一个关键组成部分,它显示出抑郁症治疗的前景. 催眠干预,类似于指导图像,可以增强抑郁症的行为激活.
科学领域:
- 精神病学和行为科学
- 临床心理学 临床心理学
背景情况:
- 抑郁症是一个重大的全球健康挑战,带来了巨大的个人和经济成本.
- 抑郁症的最佳治疗通常涉及心理治疗和药物治疗的结合.
- 行为激活 (BA) 是认知行为疗法 (CBT) 的核心组成部分,也是有效的独立抑郁症治疗方法.
研究的目的:
- 审查关于应用催眠来促进抑郁症行为激活的文献.
- 解决关于基于催眠的BA干预的研究差距.
- 探索临床医生指导的可视化和图像练习在抑郁症治疗中的重要性.
主要方法:
- 关于催眠和抑郁症行为激活现有研究的文献综述.
- 与BA相关的临床指导可视化和图像练习的分析.
- 检查催眠和其他CBT技术之间的相似之处.
主要成果:
- 证据支持临床医生指导的可视化和图像在通过行为激活治疗抑郁症的有效性.
- 虽然没有明确标记为催眠,但这些干预措施与传统的催眠技术有很大的相似之处.
- 关于直接应用催眠来促进抑郁症中BA的研究正在出现,但有限.
结论:
- 临床医生指导的可视化和图像练习在促进抑郁症行为激活方面表现出有效性.
- 催眠干预可能是一个有价值的,未被充分探索的途径,用于增强抑郁症治疗中的行为激活.
- 对于研究人员和临床医生来说,建议对相关文献进行更广泛的考虑,以探索抑郁症的催眠.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
248
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
248
The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
Sedatives and Hypnotics: Overview
403
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
403
Altered States of Awareness
203
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
203
Sedatives and Hypnotics Drugs: Miscellaneous Agents
180
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
180
Electroconvulsive Therapy
44
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
44


